You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
重藥控股(000950.SZ):大足國資公司擬摘牌受讓重藥大足醫管65%股權及1616萬元債權
格隆匯 01-13 16:59

格隆匯 1 月 13日丨重藥控股(000950.SZ)公佈,因行業政策變化,同時結合公司未來發展規劃,公司下屬控股子公司重慶醫藥集團頤合健康產業有限公司(“重藥頤合”)於2020年12月2日,在重慶聯合產權交易所(“重慶聯交所”)掛牌對外轉讓所持重慶醫藥集團大足醫院管理有限公司(“重藥大足醫管”)65%股權及1616萬元債權,掛牌底價為1.11億元(包含前述股權價值及1616萬元債權)。

2021年1月12日,重慶大足國有資產經營管理集團有限公司(“大足國資公司”)以1.1137億元價格摘牌受讓重藥頤合此次對外轉讓所持重藥大足醫管65%股權及1616萬元債權,並與重藥頤合簽訂《產權交易合同》。

重藥大足醫管原為公司控股子公司,此次對外轉讓後將減少公司合併報吿範圍。因重藥大足醫管司主要工作為投資重慶市大足區第二人民醫院遷建項目(一期工程籌備和建設,尚未開展經營性業務,所以不會影響公司正常經營。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account